{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:03:42Z","timestamp":1773007422156,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00415-012-6619-y","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T10:29:28Z","timestamp":1344508168000},"page":"2393-2400","source":"Crossref","is-referenced-by-count":13,"title":["FabryScan: a screening tool for early detection of Fabry disease"],"prefix":"10.1007","volume":"259","author":[{"given":"Kathrin","family":"Arning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Naleschinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Maag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"Biegstraaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Lorenzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla E. M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo N.","family":"Schaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontus","family":"Harten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainald A.","family":"Zeuner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"issue":"9647","key":"6619_CR1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372(9647):1427\u20131435","journal-title":"Lancet"},{"issue":"9499","key":"6619_CR2","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","volume":"366","author":"A Rolfs","year":"2005","unstructured":"Rolfs A et al (2005) Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366(9499):1794\u20131796","journal-title":"Lancet"},{"issue":"1","key":"6619_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","volume":"122","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R (2009) Fabry disease. Pharmacol Ther 122(1):65\u201377","journal-title":"Pharmacol Ther"},{"key":"6619_CR4","volume-title":"The metabolic and molecular bases of inherited disease","year":"2001","unstructured":"Scriver CR, Beaudet AL, Sly WS et al (eds) (2001) The metabolic and molecular bases of inherited disease, 8th edn. McGraw, New York","edition":"8"},{"issue":"1","key":"6619_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M et al (2006) High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79(1):31\u201340","journal-title":"Am J Hum Genet"},{"key":"6619_CR6","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JMGJ Aerts","year":"2008","unstructured":"Aerts JMGJ et al (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105:2812\u20132817","journal-title":"Proc Natl Acad Sci USA"},{"key":"6619_CR7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/jhg.2010.58","volume":"55","author":"BHHS Lee","year":"2010","unstructured":"Lee BHHS et al (2010) Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns. J Hum Genet 55:512\u2013517","journal-title":"J Hum Genet"},{"issue":"5","key":"6619_CR8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpeds.2010.02.012","volume":"156","author":"CL Marchesoni","year":"2010","unstructured":"Marchesoni CL et al (2010) Misdiagnosis in Fabry disease. J Pediatr 156(5):828\u2013831","journal-title":"J Pediatr"},{"issue":"3","key":"6619_CR9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A et al (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34(3):236\u2013242","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"6619_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mus.20130","volume":"31","author":"D Lacomis","year":"2005","unstructured":"Lacomis D, Roeske-Anderson L, Mathie L (2005) Neuropathy and Fabry\u2019s disease. Muscle Nerve 31(1):102\u2013107","journal-title":"Muscle Nerve"},{"issue":"9","key":"6619_CR11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","volume":"103","author":"A Mehta","year":"2010","unstructured":"Mehta A et al (2010) Fabry disease: a review of current management strategies. QJM 103(9):641\u2013659","journal-title":"QJM"},{"issue":"1","key":"6619_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry\u2019s disease. N Engl J Med 345(1):9\u201316","journal-title":"N Engl J Med"},{"issue":"21","key":"6619_CR13","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R et al (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285(21):2743\u20132749","journal-title":"JAMA"},{"issue":"11","key":"6619_CR14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","volume":"11","author":"S Waldek","year":"2009","unstructured":"Waldek S et al (2009) Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry registry. Genet Med 11(11):790\u2013796","journal-title":"Genet Med"},{"issue":"9706","key":"6619_CR15","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0140-6736(09)61493-8","volume":"374","author":"A Mehta","year":"2009","unstructured":"Mehta A et al (2009) Enzyme replacement therapy with agalsidase alfa in patients with Fabry\u2019s disease: an analysis of registry data. Lancet 374(9706):1986\u20131996","journal-title":"Lancet"},{"issue":"2","key":"6619_CR16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0407","volume":"3","author":"AT Moller","year":"2007","unstructured":"Moller AT, Jensen TS (2007) Neurological manifestations in Fabry\u2019s disease. Nat Clin Pract Neurol 3(2):95\u2013106","journal-title":"Nat Clin Pract Neurol"},{"key":"6619_CR17","unstructured":"Ginsberg L (2006) Nervous system manifestations of Fabry disease: data from FOS\u2014the Fabry outcome survey"},{"issue":"439","key":"6619_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2002.tb03108.x","volume":"91","author":"MJ Hilz","year":"2002","unstructured":"Hilz MJ (2002) Evaluation of peripheral and autonomic nerve function in Fabry disease. Acta Paediatr Suppl 91(439):38\u201342","journal-title":"Acta Paediatr Suppl"},{"issue":"3","key":"6619_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","volume":"123","author":"R Rolke","year":"2006","unstructured":"Rolke R et al (2006) Quantitative sensory testing in the German research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain 123(3):231\u2013243","journal-title":"Pain"},{"issue":"3","key":"6619_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pain.2010.05.002","volume":"150","author":"C Maier","year":"2010","unstructured":"Maier C et al (2010) Quantitative sensory testing in the German research network on neuropathic pain (DFNS): somatosensory abnormalities in 1,236 patients with different neuropathic pain syndromes. Pain 150(3):439\u2013450","journal-title":"Pain"},{"issue":"8","key":"6619_CR21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1526-4637.2008.00470.x","volume":"9","author":"R Maag","year":"2008","unstructured":"Maag R et al (2008) Detection of a characteristic painful neuropathy in Fabry disease: a pilot study. Pain Med 9(8):1217\u20131223","journal-title":"Pain Med"},{"issue":"6","key":"6619_CR22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","volume":"19","author":"M Dutsch","year":"2002","unstructured":"Dutsch M et al (2002) Small fiber dysfunction predominates in Fabry neuropathy. J Clin Neurophysiol 19(6):575\u2013586","journal-title":"J Clin Neurophysiol"},{"issue":"8","key":"6619_CR23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ejpain.2011.01.014","volume":"15","author":"M Biegstraaten","year":"2011","unstructured":"Biegstraaten M et al (2011) The relation between small nerve fibre function, age, disease severity and pain in Fabry disease. Eur J Pain 15(8):822\u2013829","journal-title":"Eur J Pain"},{"issue":"9","key":"6619_CR24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D et al (2010) Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6619_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","volume":"64","author":"JD England","year":"2005","unstructured":"England JD et al (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American academy of neurology, the American association of electrodiagnostic medicine, and the American academy of physical medicine and rehabilitation. Neurology 64(2):199\u2013207","journal-title":"Neurology"},{"issue":"4","key":"6619_CR26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","volume":"65","author":"C Whybra","year":"2004","unstructured":"Whybra C et al (2004) The mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65(4):299\u2013307","journal-title":"Clin Genet"},{"key":"6619_CR27","first-page":"573","volume":"57","author":"G Schwarzer","year":"2002","unstructured":"Schwarzer G, T\u00fcrp JC, Antes G (2002) EbM-Splitter: nutzen diagnostischer tests in der praxis: pr\u00e4diktive Werte. Dtsch Zahn\u00e4rztl Z 57:573\u2013575","journal-title":"Dtsch Zahn\u00e4rztl Z"},{"key":"6619_CR28","first-page":"333","volume":"57","author":"G Schwarzer","year":"2002","unstructured":"Schwarzer G, T\u00fcrp JC, Antes G (2002) EbM-Splitter: die vierfeldertafel (in diagnosestudien): sensitivit\u00e4t und Spezifit\u00e4t. Dtsch Zahn\u00e4rztl Z 57:333","journal-title":"Dtsch Zahn\u00e4rztl Z"},{"key":"6619_CR29","first-page":"446","volume":"57","author":"G Schwarzer","year":"2002","unstructured":"Schwarzer G, T\u00fcrp JC, Antes G (2002) EbM-spliter: sensitivit\u00e4t und spezifit\u00e4t: die auswirkung der wahl des trennpunktes. Dtsch Zahn\u00e4rztl Z 57:446\u2013447","journal-title":"Dtsch Zahn\u00e4rztl Z"},{"issue":"1","key":"6619_CR30","first-page":"83","volume":"29","author":"CM Florkowski","year":"2008","unstructured":"Florkowski CM (2008) Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. Clin Biochem Rev 29(1):83\u201387","journal-title":"Clin Biochem Rev"},{"key":"6619_CR31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1037\/0021-9010.78.1.98","volume":"78","author":"JM Cortina","year":"1993","unstructured":"Cortina JM (1993) What is coefficient alpha? An examination of theory and applications. J Appl Psychol 78:98\u2013104","journal-title":"J Appl Psychol"},{"issue":"2","key":"6619_CR32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/1094428105284919","volume":"9","author":"CE Lance","year":"2006","unstructured":"Lance CE, Butts MM, Michels LC (2006) The sources of four commonly reported cut off criteria: what did they really say? Organ Res Methods 9(2):202\u2013220","journal-title":"Organ Res Methods"},{"issue":"3","key":"6619_CR33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ et al (1999) Prevalence of lysosomal storage disorders. JAMA 281(3):249\u2013254","journal-title":"JAMA"},{"issue":"10","key":"6619_CR34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu WL et al (2009) Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A(IVS4+919G>A). Hum Mutat 30(10):1397\u20131405","journal-title":"Hum Mutat"},{"issue":"11","key":"6619_CR35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/GIM.0b013e3181f13a4a","volume":"12","author":"T Watt","year":"2004","unstructured":"Watt T et al (2004) Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry registry. Genet Med 12(11):703\u2013712","journal-title":"Genet Med"},{"issue":"3","key":"6619_CR36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pain.2006.10.034","volume":"127","author":"MI Bennett","year":"2007","unstructured":"Bennett MI et al (2007) Using screening tools to identify neuropathic pain. Pain 127(3):199\u2013203","journal-title":"Pain"},{"issue":"4","key":"6619_CR37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","volume":"43","author":"PB Deegan","year":"2006","unstructured":"Deegan PB et al (2006) Natural history of Fabry disease in females in the Fabry outcome survey. J Med Genet 43(4):347\u2013352","journal-title":"J Med Genet"},{"issue":"6","key":"6619_CR38","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.clinph.2008.02.004","volume":"119","author":"SM Laaksonen","year":"2008","unstructured":"Laaksonen SM et al (2008) Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol 119(6):1365\u20131372","journal-title":"Clin Neurophysiol"},{"issue":"1\u20132","key":"6619_CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2009.06.032","volume":"145","author":"A Torvin Moller","year":"2009","unstructured":"Torvin Moller A et al (2009) Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain 145(1\u20132):237\u2013245","journal-title":"Pain"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6619-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6619-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:23:06Z","timestamp":1559071386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6619-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["6619"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6619-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]}}}